Growth Metrics

Pharma-Bio Serv (PBSV) Other Working Capital Changes (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Other Working Capital Changes readings, the most recent being -$39716.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 5.24% to -$39716.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$310291.0, a 1021.4% decrease, with the full-year FY2025 number at -$308312.0, down 1527.7% from a year prior.
  • Other Working Capital Changes hit -$39716.0 in Q1 2026 for Pharma-Bio Serv, up from -$336215.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $220778.0 in Q3 2022 to a low of -$336215.0 in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was $11453.0 (2023), compared with a mean of -$2863.1.
  • The widest YoY moves for Other Working Capital Changes: up 439.29% in 2025, down 683.46% in 2025.
  • Pharma-Bio Serv's Other Working Capital Changes stood at $197507.0 in 2022, then tumbled by 167.55% to -$133410.0 in 2023, then soared by 143.19% to $57624.0 in 2024, then crashed by 683.46% to -$336215.0 in 2025, then skyrocketed by 88.19% to -$39716.0 in 2026.
  • The last three reported values for Other Working Capital Changes were -$39716.0 (Q1 2026), -$336215.0 (Q4 2025), and $96317.0 (Q3 2025) per Business Quant data.